2016
EASD 2016
Mohammad Alhadj Ali
Dr. Mohammad Alhadj Ali
Proinsulin peptide immunotherapy in new-onset type 1 diabetes is well-tolerated and associated with reduced daily insulin usage || Abstract #108
There are no comments yet. Be the first one to post a comment.
Related To This Abstract